AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vriglim-M 4 Tablet PR

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Vriglim-M 4 Tablet PR

Diabetace-Duo 4mg tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This formulation helps regulate blood glucose. Always take Diabetace-Duo 4mg with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as prescribed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (like sugary snacks or juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before starting Diabetace-Duo 4mg. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.

Primary Ingredients of Vriglim-M 4 Tablet PR

No text provided. Please provide the text you wish me to rephrase.

Uses of Vriglim-M 4 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Vriglim-M 4 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Administer Vriglim-M 4 Tablet PR with a meal.

Common Side effects of Vriglim-M 4 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Vriglim-M 4 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Vriglim-M 4 Tablet PR with a meal.

How Vriglim-M 4 Tablet PR works:

Vriglim-M 4 PR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vriglim-M 4 Tablet PR and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vriglim-M 4 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Vriglim-M 4 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vriglim-M 4 Tablet PR, as dosage modification may be necessary. Severe kidney disease contraindicates the use of Vriglim-M 4 Tablet PR. Consult a physician for guidance. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Vriglim-M 4 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, a low initial dose is typically prescribed; however, Vriglim-M 4 Tablet PR is contraindicated in cases of severe liver disease.

What if you forget to take Vriglim-M 4 Tablet PR :

Should you forget a dose of Vriglim-M 4 Tablet PR, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual dosing schedule. Never take a double dose.

Facts to Know About Vriglim-M 4 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vriglim-M 4 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Vriglim-M 4 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Vriglim-M 4 Tablet PR and seek immediate medical attention.
Vriglim-M 4 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for treating type 1 DM.
Vriglim-M 4 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Vriglim-M 4 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Vriglim-M 4 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Vriglim-M 4 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Vriglim-M 4 Tablet PR
107
MRP 124
13% off